Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Ruilope

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Advances in Therapy|August 23, 2014
Additional information regarding the SEVITENSION studyLuis Ruilope
Blood Pressure|April 21, 2017
Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor BlockadeLuis Ruilope
Advances in Therapy|December 3, 2013
The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertensionLuis Ruilope, Angie Schaefer
Expert Opinion on Pharmacotherapy|January 9, 2003
Eprosartan for the treatment of hypertensionLuis Ruilope, Bodo Jäger
Advances in Therapy|February 26, 2015
Erratum to: The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertensionLuis Ruilope, Angie Schaefer
F1000Research|May 23, 2017
The impact of antihypertensives on kidney diseaseDiego F Marquez, Gema Ruiz-Hurtado, Luis Ruilope
Advances in Therapy|July 19, 2017
Practical Considerations for the Use of Subcutaneous Treatment in the Management of DyslipidaemiaFranck Boccara, Ricardo Dent, Luis Ruilope, et al.
Journal of the American Society of Hypertension : JASH|December 7, 2013
Review of blood pressure control rates and outcomesGeorge Bakris, Pantelis Sarafidis, Rajiv Agarwal, et al.
F1000Research|October 5, 2019
Microalbuminuria and cardiorenal risk: old and new evidence in different populationsDiego Francisco Márquez, Gema Ruiz-Hurtado, Julian Segura, et al.
Lancet (London, England)|August 18, 2017
Born to run: our future depends on itAlejandro Santos-Lozano, Alejandro Lucia, Luis Ruilope, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Advances in Therapy|August 23, 2014
Additional information regarding the SEVITENSION studyLuis Ruilope
Blood Pressure|April 21, 2017
Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor BlockadeLuis Ruilope
Advances in Therapy|December 3, 2013
The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertensionLuis Ruilope, Angie Schaefer
Expert Opinion on Pharmacotherapy|January 9, 2003
Eprosartan for the treatment of hypertensionLuis Ruilope, Bodo Jäger
Advances in Therapy|February 26, 2015
Erratum to: The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertensionLuis Ruilope, Angie Schaefer
F1000Research|May 23, 2017
The impact of antihypertensives on kidney diseaseDiego F Marquez, Gema Ruiz-Hurtado, Luis Ruilope
Advances in Therapy|July 19, 2017
Practical Considerations for the Use of Subcutaneous Treatment in the Management of DyslipidaemiaFranck Boccara, Ricardo Dent, Luis Ruilope, et al.
Journal of the American Society of Hypertension : JASH|December 7, 2013
Review of blood pressure control rates and outcomesGeorge Bakris, Pantelis Sarafidis, Rajiv Agarwal, et al.
F1000Research|October 5, 2019
Microalbuminuria and cardiorenal risk: old and new evidence in different populationsDiego Francisco Márquez, Gema Ruiz-Hurtado, Julian Segura, et al.
Lancet (London, England)|August 18, 2017
Born to run: our future depends on itAlejandro Santos-Lozano, Alejandro Lucia, Luis Ruilope, et al.
Pageof 7